Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 1.00 |
| ▸ | EGFR | P00533 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | OPRD1 | P41143 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | CASR | P41180 | 13/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Proquazone SCHEMBL29508590 | 1.00 | NR1I2 (1.00) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| Proquazone SCHEMBL2931942 | 0.99 | NR1I2 (0.97) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL11565990 | 0.92 | NR1I2 (0.85) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| Proquazone SCHEMBL11339177 | 0.89 | NR1I2 (0.79) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL11723933 | 0.87 | NR1I2 (0.77) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| Fluproquazone SCHEMBL29363976 | 0.87 | NR1I2 (0.77) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| Fluproquazone SCHEMBL26210 | 0.87 | NR1I2 (0.77) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL11605525 | 0.86 | NR1I2 (0.76) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL11421197 | 0.85 | NR1I2 (0.74) | NR1I2EGFRADRA2AADORA3TBXA2R | |
| SCHEMBL7680445 | 0.84 | NR1I2 (0.72) | NR1I2EGFRADRA2AADORA3TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11218 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4742996-A1 | SURGICAL CONSTRUCTS AND METHODS OF TISSUE FIXATION | Arthrex Inc (US) | 2026-05-20 | — | — | EP | claimed |
| EP-4719280-A1 | ANTERIOR TIBIAL APPROACH FOR TOTAL ANKLE REPLACEMENT | Arthrex, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4661772-A2 | ELASTIC SUTURES AND METHODS OF MAKING AND USE | Arthrex, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2025034353-A1 | SURGICAL CONSTRUCTS AND METHODS OF TISSUE FIXATION | ARTHREX, INC. (US) | 2025-02-13 | — | — | WO | claimed |
| US-20250041208-A1 | NEW INJECTABLE COMBINATION FORMULATION | NANEXA AB (SE) | 2025-02-06 | — | — | US | claimed |
| WO-2025006523-A1 | ANTERIOR TIBIAL APPROACH FOR TOTAL ANKLE REPLACEMENT | ARTHREX, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| EP-4444277-A1 | NEW INJECTABLE COMBINATION FORMULATION | Nanexa AB (SE) | 2024-10-16 | — | — | EP | claimed |
| WO-2024196904-A2 | ELASTIC SUTURES AND METHODS OF MAKING AND USE | ARTHREX, INC. (US) | 2024-09-26 | — | — | WO | claimed |
| WO-2024105529-A1 | CHEMICAL DISBUDDING OF LIVESTOCK | MASSEY UNIVERSITY (NZ) | 2024-05-23 | — | — | WO | claimed |
| EP-4335413-A2 | PROSTHETIC TISSUE VALVES | Cormatrix Cardiovascular, Inc. (US) | 2024-03-13 | — | — | EP | claimed |
| EP-0644755-A1 | SURFACE MODIFIED NSAID NANOPARTICLES. | EASTMAN KODAK CO (US) | 1995-03-29 | — | — | EP | claimed |
| WO-1993025190-A1 | SURFACE MODIFIED NSAID NANOPARTICLES | EASTMAN KODAK COMPANY (US) | 1993-12-23 | — | — | WO | claimed |
| EP-0111456-B1 | ANALGESIC COMBINATIONS | Cooper, Stephen A. Dr. (US) | 1989-07-12 | — | — | EP | claimed |
| EP-0028410-B1 | USE OF THROMBOXANE-SYNTHETASE INHIBITING COMPOUNDS IN THE TREATMENT OF OBESITY AND THE LOWERING OF INSULIN LEVELS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1987-09-30 | — | — | EP | claimed |
| WO-1984002273-A1 | ANALGESIC COMBINATIONS | SANDOZ AG (CH) | 1984-06-21 | — | — | WO | claimed |
| EP-0111456-A1 | Analgesic combinations | Cooper, Stephen A. Dr. (US) | 1984-06-20 | — | — | EP | claimed |
| US-4442084-A | ABSORPTION, LIQUID PHASE CLAUS PROCESS, RECYCLING | SANDOZ LTD. (CH) | 1984-04-10 | — | — | US | claimed |
| EP-0028410-A1 | Use of thromboxane-synthetase inhibiting compounds in the treatment of obesity and the lowering of insulin levels | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-05-13 | — | — | EP | claimed |
| US-4236006-A | Preparation of quinazolin-2(1H)-ones | SANDOZ LTD. (CH) | 1980-11-25 | — | — | US | claimed |
| US-4224328-A | Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors | SANDOZ, INC. (US) | 1980-09-23 | — | — | US | claimed |